Dementia is defined as a gradual alteration in mental and cognitive capabilities. It can manifest in the form of language, memory or behavioral changes signaling a decline from the previous level of function.
Incidence
- The prevalence of dementia in the population greatly increases with age. While only
1% of the population experiences dementia by age 60, by age 85 at least 50% of the
population is affected.
- Currently, an estimated 1.5 million people have severe dementia and an additional
1-5 million persons have mild to moderate dementia .
- The majority of dementia cases, 60-70%, are attributed to Alzheimers disease (AD).
- The second most common form is vascular dementia, which accounts for 10-20% of
dementia patients .
- Less common causes of dementia include Lewy body dementia, Pick's disease,
Creutzfeldt-Jakob disease, hydrocephalus, Parkinson's disease, brain tumors, and metabolic
disorders.
Table: Common symptoms of dementia
Type of Deficit | Common Presentations |
Cognitive | Impairments in language, praxis, judgment, visuospatial function, related mental activities |
Extrapyramidal | Rigidity, bradykinesia, movement disorders, abnormalities of gait |
Functional | Loss of ability to perform personal care tasks, changes in social functioning |
Neurologic | Visual field deficits, hemiparesis, hemisensory loss, asymmetric deep tendon reflexes, unilateral extensor plantar response |
Personality | Indifference, regression, impulsiveness |
Clinical Presentations
- Dementia is characterized by gradual and progressive memory impairment.
- Memory loss, naming problems, forgetting items, and visuospatial confusion characterize
the early stage of dementia.
- The middle stage is characterized by loss of reading ability, decreased performance in
social situations, increased difficulty in finding words and names, intermittent disorientation
to time, inability to recognize familiar persons, behavioral problems, and
losing directions.
- Late-stage symptoms include extreme disorientation, inability to dress and perform
self-care, increasing delusions, hallucinations, and progressive loss of other activities of
daily living and personality change.
- Rapid deterioration of mildly demented individuals is sometimes prompted by urinary
tract infection, congestive heart failure, hypothyroidism, or delirium.
- Emergency treatment of dementia may be necessary if aggression, psychosis, or activity
disturbances are present.
- Risk factors for dementia include advanced age, family history, and abnormal
apolipoprotein status.
Diagnostic Evaluation
- Generally, patients should be evaluated for dementia if any of the following are present:
- Memory or cognitive complaints with or without functional impairment
- Questions of competency in elderly patients
- Depression or anxiety in patients with cognitive complaints, or physician suspicion
of cognitive impairment during a clinical interview.
- If suspicion of dementia exists, reversible causes such as subdural hematoma, normal
pressure hydrocephalus, hypothyroidism, and the dementia syndrome Serotonin syndrome of depression
must be eliminated to make a definitive diagnosis.
- Lab tests commonly used in the assessment of dementia include complete blood count,
serum electrolytes, calcium, glucose, BUN, creatinine, liver function tests, serum B12,
Table: Diagnostic criteria of dementia according to WHO
Diagnostic Criteria for Dementia
- Decline in verbal and nonverbal memory, significant decrease in ability to learn new information, present for at least 6 mo
- Decrease from premorbid levels in cognitive abilities such as planning and organizing and general processing of information
- Preserved awareness of environment, delirium is absent
- Decline in emotional control or motivation or a change in social behavior
|
Table: DSM IV diagnostic criteria for AD
Diagnostic Criteria for AD
- Development of multiple cognitive deficits manifested by memory impairment and
one or more of the following: aphasia, apraxia, agnosia, disturbance in executive
functioning
- Cognitive deficits cause a reduction in functioning from premorbid state
- Course is characterized by gradual onset and progressive cognitive decline
- Cognitive deficits are not caused by other central nervous system disturbances that
lead to memory and cognition deficits or systemic conditions known to cause dementia
- Deficits do not occur exclusively during delirium
- Disturbance not better accounted for by an axis 1 disorder
|
and serology for syphilis. In some cases sedimentation rate, serum folate level, HIV
testing, chest X-ray, and urinalysis should be performed.
- Mental status tests examine orientation, recent and remote memory, language, praxis,
visuospatial relations, calculations, and judgment.
- Neuroimaging is helpful in identifying potentially treatable conditions that can otherwise
be missed such as tumors, subdural hematoma, hydrocephalus, and strokes.
- Neuropsychological testing is commonly used in cases of borderline or suspicious dementia.
- Cognitive screening should examine memory, ability to calculate language,
visuospatial skills, and degree of alertness. The MMSE is commonly used to detect
cognitive impairment.
- Scanning techniques such as PET and SPECT examine cerebral function.
- EEG is not routinely performed, but it can be used to identify toxic or metabolic
disorders, partial complex seizures, or Creutzfeldt-Jakob disease.
Alzheimer's Disease (AD)
- The onset of AD is characterized by the impairment of memory and orientation,
while speech and motor abilities are preserved.
- Other clinical features include depression, anxiety, behavioral disorders and speech
difficulties.
- The ability to perform everyday activities may be hampered by impaired visuospatial
processing.
- In the early stages of AD most neurologic and extrapyramidal functions are preserved
in typical forms of the disease.
- Once a positive diagnosis of AD can be made, survival ranges from 8-10 yr.
Vascular Dementia
- The symptoms of vascular dementia largely parallel those of AD. However, diagnosis
requires not only cognitive dysfunction, but also signs of cerebrovascular disease upon
neurologic exam.
- Common physical findings include exaggerated or asymmetric deep tendon reflexes,
gait abnormalities, weakness of an extremity, hemiparesis, a unilateral extensor plantar
response, or visual field deficits.
- The presence of extrapyramidal signs in conjunction with gait abnormalities indicates
Parkinsonism, progressive supranuclear palsy, or AD.
Frontal Lobe Dementia
Treatment
- Nonpharmacologic treatment is often employed for certain manifestations of dementia
such as circadian rhythm disturbances, catastrophic reactions, and wandering.
- Pharmacologic treatment becomes necessary when agitation, physical outbursts, or
significant delusions or hallucinations are present.
- Antipsychotics are generally effective for psychotic symptoms and nonpsychotic
agitated behavior.
- Stronger neuroleptics like haloperidol have better side effect profiles than low potency
agents such as thioridazine and chlorpromazine.
- Benzodiazepines can be used if neuroleptics are contraindicated. It is generally best
to use short-acting agents like lorazepam, temazepam, and oxazepam.
Alzheimer's Disease
- Acetylcholinesterase inhibitors are commonly used to slow the breakdown of acetylcholine,
an essential neurotransmitter in cognitive functioning. These drugs have not
proven to stop or reverse the progression of AD.
- The two most commonly prescribed drugs for AD are donepezil and tacrine.
- Donepezil is regarded as the first-line treatment for dementia as it is more selective,
longer-acting, and has fewer side effects than tacrine.
- Tacrine is commonly prescribed as an alternative to donepezil. However, up to
20% of patients cannot tolerate tacrine's cholinergic side effects.
- Other AChE inhibitors that have shown efficacy but have not yet been approved in
the United States include rivastigmine, metrifonate, and galantamine.
- Besides AChE inhibitors there are alternative treatments that are sometimes used for
the treatment of AD. Commonly prescribed agents include:
- Ibuprofen (400 mg, 2-3 times/day)
- Vitamin E (800-2000 IU/day)
- Conjugated estrogens. Estrogen shows promise as a treatment for cognition, mood,
behavior, and motor disturbances associated with dementia.
- Another class of drugs that has been examined is anti-inflammatory drugs.
Anti-inflammatory drugs change the cerebral inflammatory response to amyloid
protein deposits, thereby reducing the risk of developing AD or slowing the progression
of symptoms.
Table: Nonpharmacologic interventions for dementia
Presentation | Intervention |
Verbal outbursts/ mild delusions | Reassurance Ignoring behavior Diversionary strategies |
Circadian rhythm disturbance | Avoid night time fluids Treatment of painful conditions that may be disrupting sleep Encourage daytime exercise Discourage daytime napping |
Catastrophic reactions | Approach patient in calm manner Avoid excessive external stimuli Limit demands |
Vascular Dementia
- The treatment of vascular dementia is focused on the treatment of risk factors. As
hypertension is one of the more common risk factors for vascular dementia, antihypertensive
drugs are commonly prescribed.
- Systolic blood pressure should be kept below 150-160 mm Hg and diastolic blood
pressure should be in the range of 85-95 mm Hg. Because of cerebral artherosclerosis,
treatment that lowers diastolic blood pressure below 85-95 mm Hg may worsen cognitive
impairment.
- Enteric-coated aspirin is sometimes prescribed in the range of 81-325 mg daily.
- Vitamin E, 800-2000 IU daily, is also prescribed in some cases.
|